# Interest of the Balance of Pro-coagulating and Profibrinolytis Activities of the Microparticles (MP) in the Prognosis of Septic Shock

> **NCT02062970** · NA · UNKNOWN · sponsor: **Assistance Publique Hopitaux De Marseille** · enrollment: 230 (actual)

## Conditions studied

- the Coagulolytic Balance
- the Mortality Rate
- the Performance Used to Evaluate the Principal Objective Are Technical Performances, Sensibility and Specificity of the Tests

## Interventions

- **BIOLOGICAL:** blood draw

## Key facts

- **NCT ID:** NCT02062970
- **Lead sponsor:** Assistance Publique Hopitaux De Marseille
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-02
- **Primary completion:** 2018-01
- **Final completion:** 2019-09
- **Target enrollment:** 230 (ACTUAL)
- **Last updated:** 2019-05-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02062970

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02062970, "Interest of the Balance of Pro-coagulating and Profibrinolytis Activities of the Microparticles (MP) in the Prognosis of Septic Shock". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02062970. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*